Intracameral Injection of Methotrexate for Treatment of Epithelial Ingrowth Publisher



Salari F¹ ; Fakhraie G¹ ; Amoli FA¹ ; Zareighanavati M¹ Show Affiliations
Source: Journal of Current Ophthalmology Published:2022

Abstract

Purpose: To report a case of intracameral injection of methotrexate (MTX) to treat the epithelial ingrowth that occurred following glaucoma surgery. Methods: A case report of a 40-year-old male with epithelial ingrowth after implantation of Ahmed glaucoma valve. Results: The patient was treated with 11 doses of weekly intracameral MTX (400 mg/0.1 ml). Clinical evidence of recurrence was not observed after 11 months of follow-up. Discussion: Intracameral MTX can be used as an alternative for the treatment of epithelial ingrowth. © 2022 Iranian Society of Ophthalmology. All rights reserved.